Autism ALERT for Autism Spectrum Disorder

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Autism Spectrum Disorder+2 More
Autism ALERT - Other
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new way to help kids with suspected ASD receive the resources they need by making it easier for primary care providers to refer them and track their progress.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism Spectrum Disorders

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Autism Spectrum Disorder

Study Objectives

10 Primary · 7 Secondary · Reporting Duration: At enrollment and 6 months after enrollment

6 months after enrollment
% referred to program who complete an ASD educational evaluation within 6 months
Month 6
Family Satisfaction with Program
Month 6
Change in Family Centered and Coordinated Care
Change in Family Empowerment
Change in Parent stress
Change in Parenting stress
Month 9
Family self-reported ASD knowledge
Month 9
Change in provider autism paperwork burden
Change in provider self-efficacy about autism management
Month 9
Change in satisfaction with Care Coordination in general and for autism in particular
Year 1
% with ASD medical diagnosis receiving ASD therapy 6 months after enrollment, among children on Medicaid
age of ASD medical diagnosis among children on Medicaid
Month 9
% with ASD determination receiving ASD services 6 months after enrollment
Age of EI/ECSE educational determination, among children with ASD
Time from EI/ECSE referral to ASD treatment in EI/ECSE, among children with ASD
Time from EI/ECSE referral to evaluation among children with ASD
monthly service hours among children with ASD 6 months after enrollment

Trial Safety

Safety Progress

1 of 3

Other trials for Autism Spectrum Disorder

Trial Design

2 Treatment Groups

Screening Only
1 of 2
Screening + Autism ALERT
1 of 2
Active Control
Experimental Treatment

148 Total Participants · 2 Treatment Groups

Primary Treatment: Autism ALERT · No Placebo Group · N/A

Screening + Autism ALERTExperimental Group · 2 Interventions: Autism ALERT, Screening Intervention · Intervention Types: Other, Other
Screening Only
Other
ActiveComparator Group · 1 Intervention: Screening Intervention · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: at enrollment and 6 months after enrollment

Who is running the clinical trial?

Providence Health & ServicesOTHER
106 Previous Clinical Trials
50,697 Total Patients Enrolled
Oregon Health and Science UniversityLead Sponsor
885 Previous Clinical Trials
6,828,393 Total Patients Enrolled
5 Trials studying Autism Spectrum Disorder
677 Patients Enrolled for Autism Spectrum Disorder
Boston Medical CenterOTHER
357 Previous Clinical Trials
876,963 Total Patients Enrolled
4 Trials studying Autism Spectrum Disorder
512 Patients Enrolled for Autism Spectrum Disorder

Eligibility Criteria

Age < 18 · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 14th, 2021

Last Reviewed: October 23rd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.